ContextVision AB (publ) (OSL:CONTX)
Norway · Delayed Price · Currency is NOK 4.140
+0.590 (16.62%)
Aug 27, 2026, 4:25 PM CET
ContextVision AB Market Cap
ContextVision AB has a market cap or net worth of 264.51 million as of August 27, 2026. Its market cap has decreased by -25.02% in one year.
Market Cap
264.51M
Enterprise Value
205.90M
Revenue
123.94M
Ranking
n/a
PE Ratio
19.87
Stock Price
4.14
ChartMarket Cap Chart
Since March 18, 1997, ContextVision AB's market cap has decreased from 296.00M to 264.51M, a decrease of -10.64%. That is a compound annual growth rate of -0.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 264.51M | -17.16% |
| Dec 30, 2025 | 319.30M | -24.96% |
| Dec 30, 2024 | 425.52M | -28.57% |
| Dec 29, 2023 | 595.73M | -15.75% |
| Dec 30, 2022 | 707.14M | -44.49% |
| Dec 30, 2021 | 1.27B | -25.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.68B |
| Circio Holding ASA | 2.60B |
| Thor Medical ASA | 2.49B |
| Nordhealth AS | 1.85B |
| Gentian Diagnostics ASA | 595.16M |
| Lytix Biopharma ASA | 592.13M |
| Oncoinvent ASA | 377.08M |
| Navamedic ASA | 358.52M |